Obesity is a disease which leads to the development of many other disorders. Excessive
accumulation of lipids in adipose tissue (AT) leads to metabolic changes, including …

The adipose tissue has recently emerged as an important endocrine organ releasing
numerous mediators including adipocytokines, classical cytokines and others. Adiponectin …

Although adiponectin, an adipocytokine released from adipose tissue, is thought to have anti-
atherogenic, anti-inflammatory, and insulin-sensitizing effects, it appears that high, rather …

OBJECTIVE We investigated the predictive value of urinary adiponectin (uADP) for the
progression of diabetic nephropathy (DN) as well as for the principal determinants of uADP …

Background/objective Loss of renal function may induce secondary hyperparathyroidism (s-
HPT), which triggers several complications leading to an extreme decline in quality of life …

Objectives This cross-sectional study explores the association of adipokines and interleukin-
6 (IL-6) with muscle and protein energy wasting (PEW) in children with chronic kidney …

Protein-energy malnutrition and inflammation are common and overlapping conditions in
hemodialysis patients, which are associated with increased risk of morbidity and mortality …

Introduction: Adiponectin (APN), produced by adipocytes, has direct anti-diabetic, anti-
atherogenic and anti-inflammatory properties. Circulating APN levels are lower in obesity, a …

Background Adiponectin is an adipokine secreted by adipocytes. A low adiponectin level is
a significant risk factor of diabetes mellitus and cardiovascular disease. Recent studies have …

Purpose Disrupted bone metabolism in patients with chronic kidney disease (CKD) is
associated with elevated concentrations of biochemical bone markers. Recently, animal …